To Trip or Not to Trip? Why Non-Hallucinogenic Treatments Must Be Part of the Solution

The therapeutic benefits of psychedelic medicines may not require the psychoactive effects.

COMP360 Psilocybin Therapy Shows Promise in Bipolar Disorder

The early results of a COMPASS Pathways clinical trial quell some concerns related to the safety of psychedelic therapy for individuals with bipolar disorder.

Ram Dass Was “Only Jewish on My Parents’ Side”

The author recalls conversations with the spiritual leader and psychedelic pioneer about his Jewish roots.

The Myth of the Psychedelic Santa

Be the nerdiest person at your holiday parties this year by dispelling one of the most persistent psychedelic history myths!

Is the High Cost of Psychedelic Therapy Worth It?

As psychedelic-assisted therapies near FDA approval, questions remain about cost, who’s paying, and how much it saves patients and insurers in the long run.

How Many Likes Does It Take to be a Psychedelic Thought Leader?

In an era where thought leaders are minted by social media metrics, some influencers may be one viral video away from being tomorrow’s psychedelic luminaries.

COMPASS’ Published Results Take its Psilocybin into Final Phase of Clinical Trials

The results of the company’s Phase 2b trial raise concerns around safety, efficacy, and money, suggesting key questions to be addressed in Phase 3.

Amplifying Global Consciousness with VR and Psychedelics

UNIFY founder Adil Kassam discusses how technology coupled with global group meditation can facilitate synchronized transformational experiences among millions of people.

Will the Psychedelic Revolution Be Medicalized?

The medicalization of psychedelics may be changing people’s minds, but can these developments result in deeper changes in how we view or access medicine?

Psychedelic Medicine Is Going Beyond PTSD and Depression

Psychedelic medicines make headlines for indications like PTSD, depression, and anxiety, but they’re being studied for a much broader range of conditions.